The popularity of Viagra initially fueled a boom for pharma, but recent changes present a murky scenario for shareholders. Off-patent alternatives are reducing profits, and ongoing litigation add additional complexity https://hamzaafav707687.jaiblogs.com/68247919/viagra-and-the-pharmaceutical-industry-a-risky-play